By Staff, Agencies

A third Covid-19 vaccine has been registered in Russia, the country's Prime Minister Mikhail Mishustin said on Saturday. The drug, dubbed CoviVac, has been developed by the Chumakov Scientific Center in Moscow.

The new vaccine uses the most old-school technology out of all of the Russian-made anti-coronavirus solutions. CoviVac is a whole virus vaccine that contains either weakened or deactivated coronaviruses, cultivated specifically for its production.

Its developers have previously said that the vast majority of vaccines worldwide have been built on this technology and using it against the COVID-19 pandemic was a viable option.

The pilot batch of 120,000 doses is expected to become available for Russia’s public in mid-March, Mishustin stated. The developers are also seeking to export the vaccine to other countries.